Uses of polypills for cardiovascular disease and evidence to date

Polypills have been approved in more than 30 countries, but worldwide experience with and availability of polypills remain limited, unlike fixed-dose combinations in other diseases such as HIV, tuberculosis, and malaria. In this Series review, we aim to propose a guide for the use of polypills in fu...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 389; no. 10073; pp. 1055 - 1065
Main Authors:	Huffman, Mark D, Xavier, Denis, Perel, Pablo
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 11.03.2017 Elsevier Limited
Subjects:	Atherosclerosis Cardiovascular disease Cardiovascular diseases Disease prevention Drug dosages Drug therapy Health risk assessment Heterogeneity Internal Medicine Lipids Malaria Pharmaceutical industry Prevention Purchasing contracts Risk assessment Risk factors Studies Tuberculosis Vector-borne diseases
ISSN:	0140-6736, 1474-547X, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!